663 related articles for article (PubMed ID: 16426212)
1. Detection of activated platelets in canine blood by use of flow cytometry.
Wills TB; Wardrop KJ; Meyers KM
Am J Vet Res; 2006 Jan; 67(1):56-63. PubMed ID: 16426212
[TBL] [Abstract][Full Text] [Related]
2. Detection of activated platelets and platelet-leukocyte aggregates in horses.
Weiss DJ; Evanson OA
Am J Vet Res; 1997 Aug; 58(8):823-7. PubMed ID: 9256963
[TBL] [Abstract][Full Text] [Related]
3. Platelet activation as a marker for in vivo prothrombotic activity: detection by flow cytometry.
Tomer A
J Biol Regul Homeost Agents; 2004; 18(2):172-7. PubMed ID: 15471223
[TBL] [Abstract][Full Text] [Related]
4. Effect of glycoprotein IIb/IIIa inhibitors on CD62p expression, platelet aggregates, and microparticles in vitro.
Matzdorff AC; Kühnel G; Kemkes-Matthes B; Pralle H; Voss R; Fareed J
J Lab Clin Med; 2000 Mar; 135(3):247-55. PubMed ID: 10711863
[TBL] [Abstract][Full Text] [Related]
5. Effects of physiologic agonists on canine whole blood flow cytometry assays of leukocyte-platelet aggregation and platelet activation.
Tarnow I; Kristensen AT; Krogh AK; Frelinger AL; Barnard MR; Michelson AD
Vet Immunol Immunopathol; 2008 Jun; 123(3-4):345-52. PubMed ID: 18405981
[TBL] [Abstract][Full Text] [Related]
6. Sulfatides activate platelets through P-selectin and enhance platelet and platelet-leukocyte aggregation.
Merten M; Beythien C; Gutensohn K; Kühnl P; Meinertz T; Thiagarajan P
Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):258-63. PubMed ID: 15528476
[TBL] [Abstract][Full Text] [Related]
7. Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets.
Sinauridze EI; Kireev DA; Popenko NY; Pichugin AV; Panteleev MA; Krymskaya OV; Ataullakhanov FI
Thromb Haemost; 2007 Mar; 97(3):425-34. PubMed ID: 17334510
[TBL] [Abstract][Full Text] [Related]
8. Thrombogenesis in sickle cell disease.
Tomer A; Harker LA; Kasey S; Eckman JR
J Lab Clin Med; 2001 Jun; 137(6):398-407. PubMed ID: 11385360
[TBL] [Abstract][Full Text] [Related]
9. [Flow cytometric 3-color analysis of circulating activated platelets and its clinical significance in ischemic cerebrovascular diseases].
Wang J; Cao L; He M
Zhonghua Yi Xue Za Zhi; 2000 Jul; 80(7):499-502. PubMed ID: 11798806
[TBL] [Abstract][Full Text] [Related]
10. Do platelet apoptosis, activation, aggregation, lipid peroxidation and platelet-leukocyte aggregate formation occur simultaneously in hyperlipidemia?
Sener A; Ozsavci D; Oba R; Demirel GY; Uras F; Yardimci KT
Clin Biochem; 2005 Dec; 38(12):1081-7. PubMed ID: 16253220
[TBL] [Abstract][Full Text] [Related]
11. The basis examination of leukocyte-platelet aggregates with CD45 gating as a novel platelet activation marker.
Nagasawa A; Matsuno K; Tamura S; Hayasaka K; Shimizu C; Moriyama T
Int J Lab Hematol; 2013 Oct; 35(5):534-41. PubMed ID: 23356866
[TBL] [Abstract][Full Text] [Related]
12. Platelet anaesthesia during extracorporeal circulation: differential effects of GP IIb/IIIa blockers on platelet activation marker P-selectin expression at hypothermia.
Straub A; Schiebold D; Wendel HP; Azevedo R; Dietz K; Ziemer G
Thromb Res; 2008; 122(3):383-9. PubMed ID: 18304613
[TBL] [Abstract][Full Text] [Related]
13. ThromboFix platelet stabilizer: advances in clinical platelet analyses by flow cytometry?
Schmidt V; Hilberg T
Platelets; 2006 Jun; 17(4):266-73. PubMed ID: 16769604
[TBL] [Abstract][Full Text] [Related]
14. Does renal carcinoma affect the expression of P-selectin on platelets?
Mantur M; Kemona H; Pietruczuk M; Wasiluk A
Neoplasma; 2002; 49(4):243-5. PubMed ID: 12382022
[TBL] [Abstract][Full Text] [Related]
15. Comparison of two platelet activation markers using flow cytometry after in vitro shear stress exposure of whole human blood.
Lu Q; Malinauskas RA
Artif Organs; 2011 Feb; 35(2):137-44. PubMed ID: 20946295
[TBL] [Abstract][Full Text] [Related]
16. Development of a whole platelet ELISA to detect circulating activated platelets.
Amrani DL; Stojanovic L; Mosesson MN; Shalev Y; Mosesson MW
J Lab Clin Med; 1995 Dec; 126(6):603-11. PubMed ID: 7490520
[TBL] [Abstract][Full Text] [Related]
17. Increased leukocyte-platelet interactions during circulatory support with left ventricular assist devices.
Radovancevic R; Matijevic N; Bracey AW; Radovancevic B; Elayda M; Gregoric ID; Frazier OH
ASAIO J; 2009; 55(5):459-64. PubMed ID: 19730003
[TBL] [Abstract][Full Text] [Related]
18. Vimentin autoantibodies induce platelet activation and formation of platelet-leukocyte conjugates via platelet-activating factor.
Leong HS; Mahesh BM; Day JR; Smith JD; McCormack AD; Ghimire G; Podor TJ; Rose ML
J Leukoc Biol; 2008 Feb; 83(2):263-71. PubMed ID: 17974709
[TBL] [Abstract][Full Text] [Related]
19. Measurement of phosphatidylserine exposure during storage of platelet concentrates using the novel probe lactadherin: a comparison study with annexin V.
Albanyan AM; Murphy MF; Rasmussen JT; Heegaard CW; Harrison P
Transfusion; 2009 Jan; 49(1):99-107. PubMed ID: 18954406
[TBL] [Abstract][Full Text] [Related]
20. Relationship between changes in platelet reactivity and changes in platelet receptor expression induced by physical exercise.
Aurigemma C; Fattorossi A; Sestito A; Sgueglia GA; Farnetti S; Buzzonetti A; Infusino F; Landolfi R; Scambia G; Crea F; Lanza GA
Thromb Res; 2007; 120(6):901-9. PubMed ID: 17337041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
